2014. Key Word(s): 1. GLP-2; 2. stress ulcer; 3. intestinal barrier function Presenting Author: Y-27632 cell line YINGQIAO ZHU Additional Authors:
YANG BAI, QI ZHANG Corresponding Author: YINGQIAO ZHU Affiliations: Ultrasound, 1st Hospital, Jilin University; Ultrasound, 1st Hospital, Jilin University Objective: Study the left gastric vein color Doppler evaluate the efficacy of endoscopic variceal ligation. Methods: 102 Patients (median age 60 years) involved in this study, all of them with significant liver cirrhosis and varices, in which 38 males (median age 58 years), females 25 (median age 62 years). All patients underwent endoscopic variceal ligation, and was carried out left gastric vein color Doppler ultrasound examination before and after ligation, respectively. Contrast the hemodynamics changes of left gastric vein before and after surgery. 2 h before and after the Ligation , resting, take the appropriate position, moderate pressure scanning, we observe the left gastric vein diameter, flow direction, flow velocity and other indicators. Effective treatment is defined as: left gastric vein flow direction restore to the liver, hepatic direction flow velocity was increased to more than 30% before surgery or reflux velocity dropped
to more than 30% before surgery. Results: 102 subjects were successfully completed by ligation, in which 85 patients with more significant changes in hemodynamics after ligation. The sensitivity and specificity of color Doppler ultrasound examination for efficacy evaluation were 83.3% and 100%, respectively. see more 17-DMAG (Alvespimycin) HCl Conclusion: The left gastric
artery color Doppler examination can overall assess Hepatogastric shunt condition by comparing before and after endoscopic variceal ligation surgery. Due to the complex diversity of the collateral circulation, left gastric vein color Doppler examination cannot make a precise assessment of all cases. Key Word(s): 1. color Doppler; 2. left gastric vein; 3. varicose veins; 4. ligation Presenting Author: XAVIER ADHOUTE Additional Authors: GUILLAUME PENARANDA, JEAN FREDERIC BLANC, JULIEN EDELINE, GUILLAUME CONROY, PAUL CASTELLANI, VALERIE OULES, OLIVIER BAYLE, OLIVIER MONNET, BERNARD POL, PATRICK BEAURAIN, HERVE PERRIER, JEAN LUC RAOUL, JEAN PIERRE BRONOWICKI, MARC BOURLIERE Corresponding Author: XAVIER ADHOUTE Affiliations: Alphabio Laboratory, Hôpital Saint-André, Centre Eugene Marquis, Chu Vandoeuvre-Lès-Nancy, Hôpital Saint-Joseph, Hôpital Saint-Joseph, Hôpital Saint-Joseph, Hôpital Saint-Joseph, Hôpital Saint-Joseph, Hôpital Saint-Joseph, Hôpital Saint-Joseph, Paoli-Calmettes Institute, Chu Vandoeuvre-Lès-Nancy, Hôpital Saint-Joseph Objective: Hepatocellular carcinoma (HCC) is often diagnosed at an advanced stage. BCLC C HCC includes a broad spectrum of tumors. The prognosis may vary with liver function and characteristics of the tumor.